PH receives 3 new Covid-19 clinical trial applications radyonatin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from radyonatin.com Daily Mail and Mail on Sunday newspapers.
By JULIA MARI ORNEDO, GMA News
Published May 25, 2021 2:06pm Three more COVID-19 vaccine developers have applied for Phase 3 clinical trials in the Philippines, a Department of Science and Technology (DOST) official said Tuesday. DOST Undersecretary Rowena Guevara said the Task Group on Vaccine Evaluation and Selection received applications from the West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd. “Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd are still completing some requirements,” she said at a health department forum. Guevara did not disclose the vaccine platform and target subjects of the three manufacturers, saying their applications are still undergoing review.
Published May 25, 2021, 2:14 PM
DOST (Manila Bulletin File photo)
Three other vaccine developers are interested in conducting a clinical trial in the Philippines for their respective coronavirus disease (COVID-19) vaccines, the Department of Science and Technology (DOST) said on Tuesday, May 25.
DOST Undersecretary Rowena Guevarra said that the three vaccine developers have already submitted their COVID-19 vaccine clinical trial applications. These are West China Hospital and Sichuan University, Shenzhen Kangtai Biological Products Co., and Eubiologics Co. Ltd.
“Evaluation of the first two new applications are ongoing, while Eubiologics Co. Ltd are still completing some requirements,” said Guevarra in an online forum hosted by the Department of Health (DOH).
WHO s COVID-19 Solidarity Vaccine Trials likely to start in April —DOST official – Manila Bulletin mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Published March 17, 2021, 1:40 PM
Twenty-one areas, mostly in Manila and Quezon City have been identified as sites for the World Health Organization (WHO) Solidarity Vaccine Trials (SVT) in the country, the Department of Science and Technology – Philippine Council for Health Research and Development (DOST-PCHRD) said Wednesday, March 17.
(JUAN CARLO DE VELA / MANILA BULLETIN)
DOST-PCHRD Executive Director Dr. Jaime C. Montoya disclosed this during the virtual town hall meeting organized by the Civil Service Commission (CSC) on the “COVID-19 Vaccine Deployment” held Wednesday.
Based on the documents presented by Montoya, seven areas in Manila City and six areas in Quezon City have been identified as WHO SVT sites. Some areas in Pasay City, San Juan City, Paranaque City and Taguig City have also been selected as vaccine trial sites.